Open access
11,833
Views
78
CrossRef citations to date
0
Altmetric
Original Article
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years
Fabio A. BarrosoDepartment of Neurology, Institute for Neurological Research Raúl Carrea, FLENI, Buenos Aires, Argentina; Correspondence[email protected]
View further author information
, View further author information
Daniel P. JudgeJohns Hopkins University Center for Inherited Heart Disease, Baltimore, MD, USA; View further author information
, Ben EbedePfizer Inc, New York, NY, USAView further author information
, Huihua LiPfizer Inc, New York, NY, USAView further author information
, Michelle StewartPfizer Inc, New York, NY, USAView further author information
, Leslie AmassPfizer Inc, New York, NY, USAView further author information
& Marla B. SultanPfizer Inc, New York, NY, USAView further author information
show all
Pages 194-204
|
Received 22 Nov 2016, Accepted 17 Jul 2017, Published online: 31 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.